Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olaf Witt

Showing results (121-130 of 242) with videos related to

Pageof 25
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2013
Histone deacetylase 10 promotes autophagy-mediated cell survivalIna Oehme, Jan-Peter Linke, Barbara C Böck, et al.
Pediatric Blood & Cancer|November 6, 2024
Soft Tissue Undifferentiated Sarcoma Carrying a Novel Onecut1::Nutm1 FusionMaria Filippidou, Stavros Glentis, Efthymia Rigatou, et al.
Cancer Research|December 19, 2025
Integrative Multiomics and Drug Sensitivity Profiling Reveal Potential Biomarkers and Therapeutic Strategies in Pediatric Solid TumorsDina ElHarouni, Rosa Hernansaiz-Ballesteros, Heike Peterziel, et al.
Pediatric Blood & Cancer|August 4, 2021
Clinical evidence for a biological effect of epigenetically active decitabine in relapsed or progressive rhabdoid tumorsMona Steinbügl, Karolina Nemes, Pascal Johann, et al.
Neuro-Oncology|December 26, 2023
Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working GroupSabine Mueller, Jason Fangusaro, Arzu Onar Thomas, et al.
Oncotarget|May 15, 2018
Transcriptome based individualized therapy of refractory pediatric sarcomas: feasibility, tolerability and efficacyBushra Weidenbusch, Günther H S Richter, Marie Sophie Kesper, et al.
Brain Pathology (Zurich, Switzerland)|October 8, 2015
Pediatric Targeted Therapy: Clinical Feasibility of Personalized Diagnostics in Children with Relapsed and Progressive TumorsFlorian Selt, Alica Deiß, Andrey Korshunov, et al.
Cancers|February 15, 2022
Local and Systemic Therapy of Recurrent Medulloblastomas in Children and Adolescents: Results of the P-HIT-REZ 2005 StudyChristine Gaab, Jonas E Adolph, Stephan Tippelt, et al.
Neuro-Oncology Advances|August 13, 2025
Cerebrospinal fluid liquid biopsy guides differential diagnosis of relapsed medulloblastoma versus secondary glioma: A case report of a pediatric patient enrolled on a <i>PDGFRA</i> inhibitor trialTom T Fischer, Kendra K Maass, Melanie Schoof, et al.
The New England Journal of Medicine|September 21, 2023
Dabrafenib plus Trametinib in Pediatric Glioma with <i>BRAF</i> V600 MutationsEric Bouffet, Jordan R Hansford, Maria Luisa Garrè, et al.
Pageof 25

Showing results (121-130 of 242) with videos related to

Sort By:
Pageof 25
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2013
Histone deacetylase 10 promotes autophagy-mediated cell survivalIna Oehme, Jan-Peter Linke, Barbara C Böck, et al.
Pediatric Blood & Cancer|November 6, 2024
Soft Tissue Undifferentiated Sarcoma Carrying a Novel Onecut1::Nutm1 FusionMaria Filippidou, Stavros Glentis, Efthymia Rigatou, et al.
Cancer Research|December 19, 2025
Integrative Multiomics and Drug Sensitivity Profiling Reveal Potential Biomarkers and Therapeutic Strategies in Pediatric Solid TumorsDina ElHarouni, Rosa Hernansaiz-Ballesteros, Heike Peterziel, et al.
Pediatric Blood & Cancer|August 4, 2021
Clinical evidence for a biological effect of epigenetically active decitabine in relapsed or progressive rhabdoid tumorsMona Steinbügl, Karolina Nemes, Pascal Johann, et al.
Neuro-Oncology|December 26, 2023
Consensus framework for conducting phase I/II clinical trials for children, adolescents, and young adults with pediatric low-grade glioma: Guidelines established by the International Pediatric Low-Grade Glioma Coalition Clinical Trial Working GroupSabine Mueller, Jason Fangusaro, Arzu Onar Thomas, et al.
Oncotarget|May 15, 2018
Transcriptome based individualized therapy of refractory pediatric sarcomas: feasibility, tolerability and efficacyBushra Weidenbusch, Günther H S Richter, Marie Sophie Kesper, et al.
Brain Pathology (Zurich, Switzerland)|October 8, 2015
Pediatric Targeted Therapy: Clinical Feasibility of Personalized Diagnostics in Children with Relapsed and Progressive TumorsFlorian Selt, Alica Deiß, Andrey Korshunov, et al.
Cancers|February 15, 2022
Local and Systemic Therapy of Recurrent Medulloblastomas in Children and Adolescents: Results of the P-HIT-REZ 2005 StudyChristine Gaab, Jonas E Adolph, Stephan Tippelt, et al.
Neuro-Oncology Advances|August 13, 2025
Cerebrospinal fluid liquid biopsy guides differential diagnosis of relapsed medulloblastoma versus secondary glioma: A case report of a pediatric patient enrolled on a <i>PDGFRA</i> inhibitor trialTom T Fischer, Kendra K Maass, Melanie Schoof, et al.
The New England Journal of Medicine|September 21, 2023
Dabrafenib plus Trametinib in Pediatric Glioma with <i>BRAF</i> V600 MutationsEric Bouffet, Jordan R Hansford, Maria Luisa Garrè, et al.
Pageof 25